001     141584
005     20240321221000.0
024 7 _ |a 10.1016/j.parkreldis.2019.09.032
|2 doi
024 7 _ |a pmid:31621617
|2 pmid
024 7 _ |a 1353-8020
|2 ISSN
024 7 _ |a 1873-5126
|2 ISSN
024 7 _ |a altmetric:67655442
|2 altmetric
037 _ _ |a DZNE-2020-07908
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Alonso-Canovas, Araceli
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
260 _ _ |a Amsterdam [u.a.]
|c 2019
|b Elsevier Science
264 _ 1 |3 print
|2 Crossref
|b Elsevier BV
|c 2019-11-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1705923574_13656
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Substantia nigra hyperechogenicity (SN+) in transcranial sonography (TCS) is frequent in Parkinson's disease (PD), while lenticular nucleus hyperechogenicity (LN+) and 3rd ventricle enlargement (3V+) are typical of Atypical Parkinsonisms (AP). However, there are no studies assessing the diagnostic yield of all TCS biomarkers in the three AP (progressive supranuclear palsy, PSP, multiple system atrophy, MSA, corticobasal degeneration, CBD). Previous references lack homogeneous criteria and data are incomprehensive.Analysis of TCS performed in routine clinical practice in AP and PD patients from two tertiary hospitals. Expert recommendations were strictly followed. Previous literature was critically analysed.155 AP (98 PSP, 40 MSA, 14 CBD), 254 PD, 145 control subjects were included. We confirmed good sensitivity for SN+ in PD (80%), but specificity was lower than reported (61%). LN+ and 3V + had moderate sensitivity for AP and PSP diagnosis respectively (65%, 63%), but specificity was higher than reported (87%, 91%). We confirmed high specificity and positive predictive value of the combination SN/LN (98%, 93% AP; 83%, 86% PD). The combinations of two or three echofeatures, previously unreported, showed high specificity but lower sensitivity (SN/3V: 75% sensitivity, 87% specificity PD; 42% sensitivity, 98% specificity PSP) (SN + LN+: 79% sensitivity, 86% specificity CBD) (SN/3V/LN: 67% sensitivity, 89% specificity PD; 29% sensitivity, 99% specificity PSP; 41% sensitivity, 95% specificity MSA; 57% sensitivity 91% specificity CBD).We present a large comprehensive study of TCS, confirming its usefulness and certain limitations in AP diagnosis. Adherence to consensus criteria is critical to implement TCS for clinical and research purposes.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
542 _ _ |i 2019-11-01
|2 Crossref
|u https://www.elsevier.com/tdm/userlicense/1.0/
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Corpus Striatum: diagnostic imaging
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Parkinsonian Disorders: diagnostic imaging
|2 MeSH
650 _ 2 |a Reproducibility of Results
|2 MeSH
650 _ 2 |a Sensitivity and Specificity
|2 MeSH
650 _ 2 |a Substantia Nigra: diagnostic imaging
|2 MeSH
650 _ 2 |a Third Ventricle: diagnostic imaging
|2 MeSH
650 _ 2 |a Ultrasonography, Doppler, Transcranial: standards
|2 MeSH
700 1 _ |a Tembl Ferrairó, José Ignacio
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Martínez-Torres, Irene
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Lopez-Sendon Moreno, Jose Luis
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Parees-Moreno, Isabel
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Monreal-Laguillo, Enric
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Pérez-Torre, Paula
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Toledano Delgado, Rafael
|0 P:(DE-HGF)0
|b 7
700 1 _ |a García Ribas, Guillermo
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Sastre Bataller, Isabel
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Masjuan, Jaime
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Martinez-Castrillo, Juan Carlos
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Walter, Uwe
|0 P:(DE-2719)9000336
|b 12
|e Last author
|u dzne
773 1 8 |a 10.1016/j.parkreldis.2019.09.032
|b : Elsevier BV, 2019-11-01
|p 40-45
|3 journal-article
|2 Crossref
|t Parkinsonism & Related Disorders
|v 68
|y 2019
|x 1353-8020
773 _ _ |a 10.1016/j.parkreldis.2019.09.032
|g Vol. 68, p. 40 - 45
|0 PERI:(DE-600)2027635-7
|q 68<40 - 45
|p 40-45
|t Parkinsonism & related disorders
|v 68
|y 2019
|x 1353-8020
856 4 _ |u https://pub.dzne.de/record/141584/files/DZNE-2020-07908_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/141584/files/DZNE-2020-07908_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:141584
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 12
|6 P:(DE-2719)9000336
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-12
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PARKINSONISM RELAT D : 2021
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-12
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-12
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-12
920 1 _ |0 I:(DE-2719)6000017
|k Rostock / Greifswald common
|l Rostock / Greifswald common
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)6000017
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21